Polyene Antifungal Drugs interact with sterols in the cell membrane (ergosterol in fungi, cholesterol in humans) to form channels through which small molecules leak from the inside of the fungal cell to the outside.
The global Polyene Antifungal Drugs API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polyene Antifungal Drugs API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polyene Antifungal Drugs API.
Report Scope
The Polyene Antifungal Drugs API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polyene Antifungal Drugs API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polyene Antifungal Drugs API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Targetmol
Merck
Biosynth
AKos Consulting & Solutions
Cayman Chemical
MolPort
Selleckchem
Gilead Sciences, Inc.
Pfizer
Bristol Myers Squibb
Teva Pharmaceuticals
Sigmapharm Laboratories
Fresenius Kabi
X-Gen Pharmaceuticals
Segment by Type
Amphotericin
Nystatin
Pimaricin
Segment by Application
Inhale
Injection
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polyene Antifungal Drugs API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Polyene Antifungal Drugs API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Polyene Antifungal Drugs API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Polyene Antifungal Drugs API Market Overview
1.1 Product Definition
1.2 Polyene Antifungal Drugs API Segment by Type
1.2.1 Global Polyene Antifungal Drugs API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Amphotericin
1.2.3 Nystatin
1.2.4 Pimaricin
1.3 Polyene Antifungal Drugs API Segment by Application
1.3.1 Global Polyene Antifungal Drugs API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Inhale
1.3.3 Injection
1.4 Global Market Growth Prospects
1.4.1 Global Polyene Antifungal Drugs API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Polyene Antifungal Drugs API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Polyene Antifungal Drugs API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Polyene Antifungal Drugs API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Polyene Antifungal Drugs API Production Market Share by Manufacturers (2019-2024)
2.2 Global Polyene Antifungal Drugs API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Polyene Antifungal Drugs API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Polyene Antifungal Drugs API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Polyene Antifungal Drugs API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Polyene Antifungal Drugs API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Polyene Antifungal Drugs API, Product Offered and Application
2.8 Global Key Manufacturers of Polyene Antifungal Drugs API, Date of Enter into This Industry
2.9 Polyene Antifungal Drugs API Market Competitive Situation and Trends
2.9.1 Polyene Antifungal Drugs API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Polyene Antifungal Drugs API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Polyene Antifungal Drugs API Production by Region
3.1 Global Polyene Antifungal Drugs API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Polyene Antifungal Drugs API Production Value by Region (2019-2030)
3.2.1 Global Polyene Antifungal Drugs API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Polyene Antifungal Drugs API by Region (2025-2030)
3.3 Global Polyene Antifungal Drugs API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Polyene Antifungal Drugs API Production by Region (2019-2030)
3.4.1 Global Polyene Antifungal Drugs API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Polyene Antifungal Drugs API by Region (2025-2030)
3.5 Global Polyene Antifungal Drugs API Market Price Analysis by Region (2019-2024)
3.6 Global Polyene Antifungal Drugs API Production and Value, Year-over-Year Growth
3.6.1 North America Polyene Antifungal Drugs API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Polyene Antifungal Drugs API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Polyene Antifungal Drugs API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Polyene Antifungal Drugs API Production Value Estimates and Forecasts (2019-2030)
4 Polyene Antifungal Drugs API Consumption by Region
4.1 Global Polyene Antifungal Drugs API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Polyene Antifungal Drugs API Consumption by Region (2019-2030)
4.2.1 Global Polyene Antifungal Drugs API Consumption by Region (2019-2024)
4.2.2 Global Polyene Antifungal Drugs API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Polyene Antifungal Drugs API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Polyene Antifungal Drugs API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Polyene Antifungal Drugs API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Polyene Antifungal Drugs API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Polyene Antifungal Drugs API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Polyene Antifungal Drugs API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Polyene Antifungal Drugs API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Polyene Antifungal Drugs API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Polyene Antifungal Drugs API Production by Type (2019-2030)
5.1.1 Global Polyene Antifungal Drugs API Production by Type (2019-2024)
5.1.2 Global Polyene Antifungal Drugs API Production by Type (2025-2030)
5.1.3 Global Polyene Antifungal Drugs API Production Market Share by Type (2019-2030)
5.2 Global Polyene Antifungal Drugs API Production Value by Type (2019-2030)
5.2.1 Global Polyene Antifungal Drugs API Production Value by Type (2019-2024)
5.2.2 Global Polyene Antifungal Drugs API Production Value by Type (2025-2030)
5.2.3 Global Polyene Antifungal Drugs API Production Value Market Share by Type (2019-2030)
5.3 Global Polyene Antifungal Drugs API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Polyene Antifungal Drugs API Production by Application (2019-2030)
6.1.1 Global Polyene Antifungal Drugs API Production by Application (2019-2024)
6.1.2 Global Polyene Antifungal Drugs API Production by Application (2025-2030)
6.1.3 Global Polyene Antifungal Drugs API Production Market Share by Application (2019-2030)
6.2 Global Polyene Antifungal Drugs API Production Value by Application (2019-2030)
6.2.1 Global Polyene Antifungal Drugs API Production Value by Application (2019-2024)
6.2.2 Global Polyene Antifungal Drugs API Production Value by Application (2025-2030)
6.2.3 Global Polyene Antifungal Drugs API Production Value Market Share by Application (2019-2030)
6.3 Global Polyene Antifungal Drugs API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Targetmol
7.1.1 Targetmol Polyene Antifungal Drugs API Corporation Information
7.1.2 Targetmol Polyene Antifungal Drugs API Product Portfolio
7.1.3 Targetmol Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Targetmol Main Business and Markets Served
7.1.5 Targetmol Recent Developments/Updates
7.2 Merck
7.2.1 Merck Polyene Antifungal Drugs API Corporation Information
7.2.2 Merck Polyene Antifungal Drugs API Product Portfolio
7.2.3 Merck Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Merck Main Business and Markets Served
7.2.5 Merck Recent Developments/Updates
7.3 Biosynth
7.3.1 Biosynth Polyene Antifungal Drugs API Corporation Information
7.3.2 Biosynth Polyene Antifungal Drugs API Product Portfolio
7.3.3 Biosynth Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Biosynth Main Business and Markets Served
7.3.5 Biosynth Recent Developments/Updates
7.4 AKos Consulting & Solutions
7.4.1 AKos Consulting & Solutions Polyene Antifungal Drugs API Corporation Information
7.4.2 AKos Consulting & Solutions Polyene Antifungal Drugs API Product Portfolio
7.4.3 AKos Consulting & Solutions Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 AKos Consulting & Solutions Main Business and Markets Served
7.4.5 AKos Consulting & Solutions Recent Developments/Updates
7.5 Cayman Chemical
7.5.1 Cayman Chemical Polyene Antifungal Drugs API Corporation Information
7.5.2 Cayman Chemical Polyene Antifungal Drugs API Product Portfolio
7.5.3 Cayman Chemical Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Cayman Chemical Main Business and Markets Served
7.5.5 Cayman Chemical Recent Developments/Updates
7.6 MolPort
7.6.1 MolPort Polyene Antifungal Drugs API Corporation Information
7.6.2 MolPort Polyene Antifungal Drugs API Product Portfolio
7.6.3 MolPort Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 MolPort Main Business and Markets Served
7.6.5 MolPort Recent Developments/Updates
7.7 Selleckchem
7.7.1 Selleckchem Polyene Antifungal Drugs API Corporation Information
7.7.2 Selleckchem Polyene Antifungal Drugs API Product Portfolio
7.7.3 Selleckchem Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Selleckchem Main Business and Markets Served
7.7.5 Selleckchem Recent Developments/Updates
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Polyene Antifungal Drugs API Corporation Information
7.8.2 Gilead Sciences, Inc. Polyene Antifungal Drugs API Product Portfolio
7.8.3 Gilead Sciences, Inc. Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Gilead Sciences, Inc. Main Business and Markets Served
7.7.5 Gilead Sciences, Inc. Recent Developments/Updates
7.9 Pfizer
7.9.1 Pfizer Polyene Antifungal Drugs API Corporation Information
7.9.2 Pfizer Polyene Antifungal Drugs API Product Portfolio
7.9.3 Pfizer Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Pfizer Main Business and Markets Served
7.9.5 Pfizer Recent Developments/Updates
7.10 Bristol Myers Squibb
7.10.1 Bristol Myers Squibb Polyene Antifungal Drugs API Corporation Information
7.10.2 Bristol Myers Squibb Polyene Antifungal Drugs API Product Portfolio
7.10.3 Bristol Myers Squibb Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Bristol Myers Squibb Main Business and Markets Served
7.10.5 Bristol Myers Squibb Recent Developments/Updates
7.11 Teva Pharmaceuticals
7.11.1 Teva Pharmaceuticals Polyene Antifungal Drugs API Corporation Information
7.11.2 Teva Pharmaceuticals Polyene Antifungal Drugs API Product Portfolio
7.11.3 Teva Pharmaceuticals Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Teva Pharmaceuticals Main Business and Markets Served
7.11.5 Teva Pharmaceuticals Recent Developments/Updates
7.12 Sigmapharm Laboratories
7.12.1 Sigmapharm Laboratories Polyene Antifungal Drugs API Corporation Information
7.12.2 Sigmapharm Laboratories Polyene Antifungal Drugs API Product Portfolio
7.12.3 Sigmapharm Laboratories Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Sigmapharm Laboratories Main Business and Markets Served
7.12.5 Sigmapharm Laboratories Recent Developments/Updates
7.13 Fresenius Kabi
7.13.1 Fresenius Kabi Polyene Antifungal Drugs API Corporation Information
7.13.2 Fresenius Kabi Polyene Antifungal Drugs API Product Portfolio
7.13.3 Fresenius Kabi Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Fresenius Kabi Main Business and Markets Served
7.13.5 Fresenius Kabi Recent Developments/Updates
7.14 X-Gen Pharmaceuticals
7.14.1 X-Gen Pharmaceuticals Polyene Antifungal Drugs API Corporation Information
7.14.2 X-Gen Pharmaceuticals Polyene Antifungal Drugs API Product Portfolio
7.14.3 X-Gen Pharmaceuticals Polyene Antifungal Drugs API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 X-Gen Pharmaceuticals Main Business and Markets Served
7.14.5 X-Gen Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Polyene Antifungal Drugs API Industry Chain Analysis
8.2 Polyene Antifungal Drugs API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Polyene Antifungal Drugs API Production Mode & Process
8.4 Polyene Antifungal Drugs API Sales and Marketing
8.4.1 Polyene Antifungal Drugs API Sales Channels
8.4.2 Polyene Antifungal Drugs API Distributors
8.5 Polyene Antifungal Drugs API Customers
9 Polyene Antifungal Drugs API Market Dynamics
9.1 Polyene Antifungal Drugs API Industry Trends
9.2 Polyene Antifungal Drugs API Market Drivers
9.3 Polyene Antifungal Drugs API Market Challenges
9.4 Polyene Antifungal Drugs API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Targetmol
Merck
Biosynth
AKos Consulting & Solutions
Cayman Chemical
MolPort
Selleckchem
Gilead Sciences, Inc.
Pfizer
Bristol Myers Squibb
Teva Pharmaceuticals
Sigmapharm Laboratories
Fresenius Kabi
X-Gen Pharmaceuticals
听
听
*If Applicable.
